Two researchers are calling for rigorous scientific exploration of MDMA (ecstasy) to identify exactly how the drug promotes strong feelings of empathy, according to a Commentary in the journal Cell. Such research may help researchers develop new therapeutic compounds, particularly for autism and post-traumatic stress disorder (PTSD).
MDMA is described as an “empathogen,” a compound that promotes feelings of empathy and close positive social feelings in users. The drug is a strictly regulated Schedule I compound, a category reserved for substances with no accepted medical use and high abuse potential.